Abstract
Gap junctional intercellular communication (GJIC) is a homeostatic process mediated by membrane channels composed of a protein family known as connexins. Alterations to channel activity can modulate suppression or facilitation of cancer progression. These varying roles are influenced by the cancer cell genetic profile and the context-dependent mechanisms of a dynamic extracellular environment that encompasses fluctuations to nutrient availability. To better explore the effects of altered cellular metabolism on GJIC in breast cancer, we generated a derivative of the triple-negative breast cancer cell line MDA-MB-231 optimized for growth in low-glucose. Reduced availability of glucose is commonly encountered during tumor development and leads to metabolic reprogramming in cancer cells. MDA-MB-231 low-glucose adapted cells exhibited a larger size with improved cell–cell contact and upregulation of cadherin-11. Additionally, increased protein levels of connexin 43 and greater plasma membrane localization were observed with a corresponding improvement in GJIC activity compared to the parental cell line. Since GJIC has been shown to affect cellular invasion in multiple cancer cell types, we evaluated the invasive qualities of these cells using multiple three-dimensional Matrigel growth models. Results of these experiments demonstrated a significantly more invasive phenotype. Moreover, a decrease in invasion was noted when GJIC was inhibited. Our results indicate a potential response of triple-negative breast cancer cells to reduced glucose availability that results in changes to GJIC and invasiveness. Delineation of this relationship may help elucidate mechanisms by which altered cancer cell metabolism affects GJIC and how cancer cells respond to nutrient availability in this regard.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The development and progression of cancer is affected by genetic alterations within cancer cells and an ever-changing microenvironment that influences their behavior. Limitations in nutrient availability are common during tumor growth in hypoxic regions of primary tumors and colonization at metastatic sites as cancer cells encounter new tissue microenvironments (Simoes et al. 2015; DeBerardinis and Chandel 2016). In particular, heterogenous blood perfusion within tumors leads to decreased oxygen and glucose levels and a reprogramming of cellular signaling which creates new cellular phenotypes optimized for growth in these conditions (Vaupel et al. 1989; Gillies et al. 1999; Garcia-Jimenez and Goding 2019). The ability of cancer cells to adapt to these changing conditions increases their potential to survive and proliferate. This often requires utilization of secondary fuel sources for nitrogen and carbon and necessitates modifications to biochemical pathways (DeBerardinis and Chandel 2016; Pavlova and Thompson 2016).
Gap junctions are intercellular channels mediated by a family of proteins known as connexins and support cellular homeostasis by allowing the regulated passage of ions, nutrients and signaling molecules (Nielsen et al. 2012). This gap junctional intercellular communication (GJIC) is often dysregulated in cancer where it is frequently decreased due to downregulation of connexin genes, mislocalization of connexin proteins and changes to cellular adhesion junctions (Aasen et al. 2016). Numerous reports have demonstrated a causative relationship between the loss of GJIC and acquisition of cancer cell hallmarks or suppression of these features following restoration of GJIC (Mehta et al. 1991; King and Lampe 2004; Shao et al. 2005; Wang et al. 2014). However, other data have established that GJIC can also promote aggressive qualities in cancer cells (Bates et al. 2007; Ghosh et al. 2014; Hong et al. 2015; Zibara et al. 2015). Multiple models have demonstrated connexin expression and/or GJIC to be correlated with metastasis (Lamiche et al. 2012; Ogawa et al. 2012; Tang et al. 2013). Moreover, cancer cell gap junctions form between endothelial cells during metastasis, as well as stromal cells at secondary metastatic sites (el-Sabban and Pauli 1994; Chen et al. 2016). Thus, GJIC remains a dynamic process in the cancer cell, consequences of which are influenced by context-dependent mechanisms that may suppress or promote cancer cell survival and function.
An increased understanding of the role GJIC plays in cancer cell metabolism is providing important information for how gap junctions mediate the transfer of metabolites in the tumor microenvironment (Contreras et al. 2002; Dovmark et al. 2017, 2018). Conversely, to better understand the role of metabolism in regulation of GJIC, we evaluated changes in the triple-negative breast cancer cell line MDA-MB-231 when these cells adapted to low-glucose availability, a variant we refer to as MDA-MB-231LG. This derivative exhibited increased connexin protein expression and GJIC. Additionally, these cells exhibited highly invasive qualities that were affected, in part, by inhibition of GJIC.
Materials and methods
Antibodies
Antibodies targeting connexin 43, actin, vimentin, N-cadherin, E-cadherin, claudin-1, cadherin-11 (immunofluorescence), β-catenin, LC3 and horse radish peroxidase conjugated secondary antibodies were purchased from Cell Signaling (Danvers, MA, USA). Cadherin-11 antibody (western blot) and Alexa fluor conjugated secondary antibodies for immunofluorescence were purchased from Thermo Fisher Scientific (Waltham, MA, USA). GAPDH antibody was purchased from EMD Millipore. HIF1α antibody was purchased from BD Biosciences.
Cell lines and culture
MDA-MB-231 (HTB-26), Hs578T (HTB-126), MCF-7 (HTB-22) and T47D (HTB-133) cell lines were purchased from the American Type Culture Collection (ATCC; Manassas, VA, USA) and maintained in RPMI 1640 supplemented with 10% fetal bovine serum (FBS). Cells were grown in a humidified incubator at 37 °C, 5% CO2 and passaged using trypsin–EDTA. Routine screening for mycoplasma was performed via PCR detection using the Promokine PCR Mycoplasma Test Kit I/C (PromoCell, Heidelberg, Germany). MDA-MB-231LG were grown in RPMI 1640 glucose-free media supplemented with 10% FBS. All experiments involving parental and LG cells were performed in the respective media unless otherwise indicated. All cells were validated by short tandem repeat (STR)-analysis at the Northwestern University NUSeq Core Facility (Chicago, IL, USA) and compared to ATCC cell identification data for verification (Table 1, Supp. Table 1).
Proliferation and viability
Cellular proliferation and viability were measured by use of CellTiter 96 AQueous One Solution reagent (EMD Millipore) on a PerkinElmer Enspire Multimode plate reader (Waltham, MA, USA) according to manufacturer’s protocols. CellEvent Green Caspase 3/7 and SYTOX-AADvanced reagents (Invitrogen, Carlsbad, CA, USA) were used to assess caspase activity and cell integrity using a Beckman Coulter (Brea, CA, USA) CytoFLEX flow cytometer with CytExpert analysis software. Positive controls for CellEvent reagent were demonstrated with staurosporine (Caspase 3/7) and heat killing (SYTOX) (Supp. Fig. 1).
pH readings
Cells were plated at equal densities and allowed to grow for 96 h without media changes. At 96 h media from wells was removed and filtered through a 0.22 µm sterile filter and read on a Mettler-Toledo SevenEasy pH meter.
Scanning electron microscopy
Cells were grown on glass coverslips and fixed with 4% paraformaldehyde at 4 °C for 24 h. Cells were then washed with phosphate-buffered saline (PBS), dehydrated with increasing concentrations of ethanol (30%, 50%, 70%, 80%, 95% and 100% for 10 min each at 4 °C), and dried in a Leica (Wetzlar, Germany) EM CPD300 critical point dryer. Samples were then sputter-coated with 10 nm silver using a Leica EM ACE600. Cells were visualized with a JEOL (Akishima, Tokyo, Japan) JCM-6000Plus scanning electron microscope at 5 kV and 10 kV.
Fluorescence microscopy and GJIC analysis
For immunofluorescence, cells were grown on glass coverslips in 24-well plates, washed with ice cold PBS and fixed in ice cold 100% methanol at − 20 °C for 20 min. Cells were blocked in 2% bovine serum albumin (BSA) in PBS and incubated with indicated antibodies. For GJIC analysis, cells were analyzed by the method of Goldberg and quantified by flow cytometry (Goldberg et al. 1995; Czyz et al. 2000). Briefly, donor cells were labeled with 5 µM of the lipophilic permanent dye CM-DiI (Invitrogen) and 10 µM calcein-AM (Invitrogen) and cultured with non-labeled cells. Spread of calcein from donor cells (CM-DiI/calcein positive) to acceptor cells (calcein only) indicated GJIC activity as demonstrated with the highly gap junction coupled Hs578T breast cancer cell line (Supp. Fig. 2a). Images for immunofluorescence and GJIC analysis were obtained with a Leica DMi8 fluorescent microscope equipped with a Leica DFC 9000GT camera and X-Cite XLED1 fluorescence source (Lumen Dynamics, Mississauga, Ontario, Canada). Quantification of GJIC was performed using a BD Biosciences (San Jose, CA, USA) FACSCalibur flow cytometer with CellQuest Pro software using the assay described above with 0.5 µM Cell Tracker Deep Red (Invitrogen) and 0.75 µM calcein-AM (Supp. Fig. 2b). Coupling efficiency was represented as the level of GJIC activity and calculated as acceptor cells/donor cells and normalized to control.
Matrigel invasion assays
Growth factor reduced (GFR) Matrigel basement membrane matrix (Corning, NY, USA) was utilized for two different three-dimensional cell culture assays. For the embedded assay, Matrigel was diluted from 8 to 5 mg/ml using RPMI 1640 with or without glucose with 10% FBS before 300 μl was added to each well. 30 μl of 1 × 106 cells/ml were added to 270 μl of diluted Matrigel and added on top of the first layer. After approximately 30–45 min of incubation, 500 μl of appropriate medium was added to the Matrigel layers. For the on-top assay, 300 μl of Matrigel was added directly to the wells without dilution. The Matrigel layer was allowed to solidify at 37 °C and 5% CO2 for 45 min and 250 μl of 25,000 cells/ml were plated directly on top of the first Matrigel layer and allowed to incubate for 45 min. 25 μl of Matrigel was mixed with 225 μl of the appropriate medium and added to the wells. Cells were then incubated for 6 days for each assay with medium changed at 48 h.
Growth factor reduced Matrigel invasion chambers (Corning) were used for the Matrigel invasion assay. 500 μl of warm serum-free medium (± 2 mM glucose) was added to each transwell insert for 2 h in the incubator to rehydrate the Matrigel. Cell suspensions were made at a concentration of 100,000 cells/well in serum-free medium. Medium in inserts was removed after 2 h before cell suspensions were added to each insert. 750 μl of 5% FBS medium was added as a chemoattractant to the bottom of wells in the 24-well plate. The invasion assay was incubated for a total of 24 h. A sterile cotton swab was used to remove non-invasive cells from the membrane. Pre-chilled 100% methanol was used as a fixative at 500 μl per insert for approximately 20 min on an orbital shaker at 4 °C. Invading cells were stained with crystal violet or mounted to glass slides using Fluoroshield with DAPI (Thermo Fisher Scientific) for quantification and imaged using a Nikon (Minato, Tokyo, Japan) Eclipse Ti2 microscope with Fi3 camera. Quantification of DAPI was performed using NIS Elements AR software.
Western blot analysis
Whole cell lysates were collected using lysis buffer containing 25 mM Tris, pH 7.4, 5% glycerol, 1% SDS and 1× protease and phosphatase inhibitors (Thermo Fisher Scientific). Lysates were passaged through a 21-gauge needle 10× on ice, combined with Laemmli sample buffer supplemented with β-mercaptoethanol and heated at 95 °C for 10 min. Samples were separated using 12% SDS-PAGE, transferred to PVDF and detected by enhanced chemiluminescence using a Bio-Rad Gel Imager (Hercules, CA, USA). Blocking and antibody solution consisted of 5% non-fat dry milk in tris-buffered saline with 0.1% tween-20. HEK293T connexin 43 overexpression lysate and empty vector control were purchased from Novus Biologicals. Additional cell lines were used as positive controls for some proteins and analyzed under the same conditions listed above. Hs578T, N-cadherin (Hazan et al. 1997; Nieman et al. 1999); MCF7, E-cadherin (Nieman et al. 1999; Pishvaian et al. 1999); T47D, claudin-1 (Majer et al. 2016; Mattern et al. 2019). Densitometry was performed using NIH ImageJ software and proteins of interest normalized to actin.
Statistical analysis
Analysis was performed using GraphPad Prism 8. Data are presented as mean ± standard deviation (SD) and significance determined using unpaired student t test analysis. Differences were considered statistically significant at p < 0.05 (*).
Results
Characterization of MDA-MB-231LG
To examine the effects of metabolic changes on GJIC in breast cancer cells, we grew the MDA-MB-231 cell line in RPMI 1640 without glucose and supplemented with 10% FBS. Because trace amounts of glucose are present within FBS, we did not consider this media glucose-free. However, based on manufacturer’s specifications, final glucose concentration in the prepared media were below 0.130 mM. This accounted for a greater than 15× fold reduction in available glucose compared to control RPMI 1640 containing 2 mM glucose. Growth in this media decreased viability within 2–4 days of culture when evaluated using an MTT assay (Fig. 1a). To generate a population of cells optimized for growth in these conditions, we plated MDA-MB-231 at low density (20–30% confluence) and maintained surviving cells for 4–6 weeks. Media was replaced every 2 days to remove apoptotic cells and cellular debris. Small populations of surviving cells initially exhibited quiescence followed by restoration of cellular proliferation. To avoid clonal selection, surviving populations from multiple plates were combined and propagated. The growth pattern of these cells normalized and regular maintenance was initiated using continued culture in low-glucose media. The surviving population exhibited morphology that was noticeably different from the parental MDA-MB-231 (Fig. 1b). Cells were larger with rounded membranes, distinctly different from the mesenchymal morphology of the parental MDA-MB-231. These cells were designated MDA-MB-231LG for their ability to grow in low glucose conditions. MDA-MB-231LG did not acidify low-glucose culture media compared to parental cells grown under standard conditions as evidenced by the effects on phenol-red (Fig. 1c). Analysis of cellular proliferation showed a similar growth pattern (Fig. 1d). Cells appeared healthy with minimal signs of cellular stress. To confirm this, we assessed markers for apoptosis (caspase-3/7 cleavage) and overall cellular integrity (SYTOX) by flow cytometry demonstrating greater than 90% viability in low-glucose media similar to that of MDA-MB-231 grown in control media (Fig. 1e). As our growth conditions involved the reduction of glucose but did not affect oxygenation, we evaluated levels of LC3II as a marker of autophagy and hypoxia inducible factor α (HIF1α) as an indicator of response to hypoxic conditions. Indeed, greater levels of LC3II were present in the MDA-MB-231LG while HIF1α remained relatively unchanged (Fig. 1f).
Since the MDA-MB-231LG displayed considerably different morphology, we verified that the MDA-MB-231LG were a true derivative of the parental MDA-MB-231. STR-analysis was performed to validate each cell line. Both the MDA-MB-231 and MDA-MB-231LG resulted in a 9/9 match for markers established by ATCC to confirm identity of cell lines corresponding to a 100% match by these criteria (Table 1). An additional 14 markers were also examined and demonstrated > 96% similarity with the only difference at marker D18S51 corresponding to a heterozygous versus homozygous result in parental MDA-MB-231 and MDA-MB-231LG respectively.
Increased membrane contact in MDA-MB-231LG
When observed by phase microscopy, MDA-MB-231LG appeared to exhibit greater contact at the plasma membrane between cells. To examine this in more detail, we performed scanning electron microscopy of both the MDA-MB-231 and MDA-MB-231LG. Results demonstrated an expected mesenchymal phenotype in MDA-MB-231 showing an elongated appearance with overlapping membranes and minimal cell–cell junctions (Fig. 2a). In contrast, MDA-MB-231LG clearly showed an increased ability to form cell–cell junctions with non-overlapping membrane connections along portions of their plasma membranes (Fig. 2a, b). While both cell lines exhibited lamellipodia and filopodia, long pseudopodia were noted in the MDA-MB-231LG (Fig. 2a). High power analysis allowed for the observation of membrane contact between MDA-MB-231LG cells (Fig. 2b).
Due to these observations, we examined markers of epithelial-to-mesenchymal transition (EMT) to determine if re-expression of epithelial markers may account for the increased cell–cell junctions. Epithelial-cadherin (E-cadherin, CDH1) and claudin-1 (CLDN1) were not detected in either MDA-MB-231 or MDA-MB-231LG (Fig. 3a), indicating that upregulation of these markers was not responsible for the increased cell–cell attachment noted in the MDA-MB-231LG. N-cadherin (CDH2), a mesenchymal-associated cadherin was not detected in the MDA-MB-231 or the MDA-MB-231LG and levels of the intermediate filament and mesenchymal marker vimentin (VIM) remained relatively unchanged (Fig. 3a). However, MDA-MB-231 have been shown to express cadherin-11 (CDH11) and analysis in the MDA-MB-231LG demonstrated a significant increase in the levels of this attachment factor (Fig. 3a). When observed by immunofluorescence, strong membrane localization was observed throughout the cell population, particularly at sites of cell–cell contact (Fig. 3b). By comparison, cadherin-11 was observed intermittently throughout MDA-MB-231 populations. Levels of β-catenin (CTNNB1), a multi-function protein involved in both cellular signaling and cell–cell attachment, remained similar between the cell lines (Fig. 3a). However, increased fluorescence overlap of β-catenin with cadherin-11 at the plasma membrane was apparent in the MDA-MB-231LG (Fig. 3b).
Adaptation to low glucose increases connexin 43 and GJIC
We next set out to determine if the metabolic adaptations in the MDA-MB-231LG and alterations to membrane structure affected GJIC. We first examined protein levels of connexin 43 (GJA1, C×43), a major connexin protein expressed in breast tissue and found an increase in proteins levels of this connexin in the MDA-MB-231LG (Fig. 4a). C×43 is subject to significant post-translational modification and higher molecular weight species of C×43 can be detected by western blot analysis (Supp. Fig. 3). However, in both the MDA-MB-231 and MDA-MB-231LG, we did not detect higher molecular weight species of C×43 (Fig. 4a).
We then determined if membrane localization of C×43 was also affected in the MDA-MB-231LG. MDA-MB-231 showed minimal staining for C×43 that was predominantly peri-nuclear with little localization at the membrane (Fig. 4b). In contrast, MDA-MB-231LG displayed a higher degree of C×43 localization at the plasma membrane, particularly at cell junctions, indicative of gap junction formation (Fig. 4b and Supp. Fig. 4). To determine if the increase in C×43 membrane localization corresponded to functional gap junctions, a double-label dye transfer technique was performed to assess GJIC with transfer of the fluorescent dye calcein indicating active GJIC. MDA-MB-231 exhibited minimal spread of calcein while a greater number of MDA-MB-231LG were capable of transferring this dye to neighboring cells (Fig. 5a). This led to a measurable increase in GJIC when quantitatively assessed by flow cytometry (Fig. 5b).
MDA-MB-231LG exhibit increased invasive qualities
Because changes to GJIC have been shown to affect the invasive capabilities of cancer cells, we sought to evaluate if this quality was also altered in the MDA-MB-231LG. We examined the morphologic appearance of these cells in three-dimensional culture utilizing Matrigel reconstituted basement membrane matrix. Cells were embedded within Matrigel, allowing for growth in three-dimension, a condition which more closely resembles cell growth in vivo and allows for observation of phenotypic characteristics. While both MDA-MB-231 and MDA-MB-231LG formed spheroids, MDA-MB-231LG exhibited greater stellate extensions at 6 days of culture (Fig. 6a). This was confirmed by use of a second assay in which cells were grown on top of a Matrigel matrix and overlaid with additional Matrigel (Fig. 6b). This procedure allows for more clear documentation of cellular morphologies and extensions and demonstrated a more invasive phenotype in MDA-MB-231LG. To determine if these changes to three-dimensional morphology correlated to increased invasive function, Matrigel invasion chamber assays were used to quantitatively assess the ability of each cell line to invade through a three-dimensional matrix and traverse a membrane containing 8 µm pores. Cells were seeded at the top of the matrix in serum-free media and FBS was used as a chemoattractant in the lower chamber of the assay. Invading cells were stained with crystal violet and MDA-MB-231LG demonstrated a clear increase in the number of invading cells (Fig. 6c).
To more quantitatively assess the invasive capacity of the MDA-MB-231LG we adapted our invasion chamber conditions to fixation with DAPI and analyzed these images using fluorescence microscopy and computer-based software quantification. Additionally, to evaluate potential contributing effects of glucose availability on each cell line, we conducted these experiments in the presence or absence of glucose for 24 h. The MDA-MB-231LG exhibited a significantly more invasive capacity in each condition compared to MDA-MB-231 (Fig. 7a, b). The overall results with MDA-MB-231LG demonstrated significantly higher invasive qualities in each condition.
Finally, to examine a potential link between the increased GJIC in MDA-MB-231LG and their invasive qualities, we used the gap junction un-coupling agent 18α-glycyrrhetinic acid (18αGA) to reduce GJIC in MDA-MB-231LG. To decrease the possibility of non-specific effects of 18αGA, we used the minimum concentration of 18αGA capable of inhibiting GJIC at 24 h for each condition in the Matrigel invasion chamber assay. This corresponded to 10 µM in serum-free conditions (upper chamber) and 50 µM in 5% FBS (lower chamber) (Fig. 8a).18αGA under these conditions caused a slight but significant reduction in Matrigel chamber invasion of MDA-MB-231LG when compared to untreated conditions (Fig. 8b, c).
Discussion
During cancer progression, breast cancer cells exhibit a multitude of responses to the extracellular milieu in which they exist. Among these alterations are changes in GJIC and adaptation to fluctuating metabolic conditions. A better understanding of how these two processes affect each other, and how this contributes to the cancer cell phenotype, will provide important information about this relationship. In this report, we describe the generation of a metabolic variant of the MDA-MB-231 parental cell line adapted for growth in glucose-limiting conditions. These cells maintained a proliferative capacity and high viability despite reduced utilization of this carbon source. The increased levels of autophagy that we observed in the MDA-MB-231LG are likely a contributing factor to their survival, yet not high enough to induce autophagic (type II) cell death. We believe that generation of the MDA-MB-231LG represent a metabolic adaptation to these growth parameters due to their significantly altered morphology as well as the molecular and functional changes we have characterized. However, persistent subpopulations within the MDA-MB-231 have been reported (Louie et al. 2010; Wang et al. 2015; Amaro et al. 2016; Morata-Tarifa et al. 2016). Therefore, the possibility that the MDA-MB-231LG represent isolation of an existing variant through the selective metabolic pressure described in our experiments remains possible. Although these cells displayed significant differences in appearance and function compared to the parental MDA-MB-231, STR analysis validated these cells a true derivative. Thus, we evaluated the characteristics of the MDA-MB-231LG on GJIC and invasion to determine how this metabolic adaptation affected these qualities.
The MDA-MB-231 cell line was originally isolated from a pleural effusion of a patient with an intraductal carcinoma and displayed rounded to spindle-like morphology following establishment in culture (Cailleau et al. 1974). Cells were isolated post-chemotherapeutic treatment and displayed significant aneuploidy. Molecular characterization has revealed a triple-negative profile with mutations in numerous genes including TP53, BRAF and KRAS (Hollestelle et al. 2010). The MDA-MB-231 exhibit a phenotype consistent with EMT and express mesenchymal markers such as the intermediate filament vimentin and lack of epithelial proteins such as E-cadherin (Nieman et al. 1999; Pishvaian et al. 1999; Li et al. 2011; Liu et al. 2015). MDA-MB-231 also fall in the category of “claudin-low” due to their decreased expression of tight junction proteins such as claudin-1 (Majer et al. 2016; Dias et al. 2017; Chiang et al. 2019; Mattern et al. 2019). Collectively, this promotes a decrease in cell–cell attachment and increase in cellular motility. Because the MDA-MB-231LG exhibited stronger cell–cell contacts and altered morphology, we explored if these cells underwent a reversal of this process known as mesenchymal-to-epithelial transition (MET) by analysis of cytoskeletal and membrane EMT markers (Chao et al. 2010; Liu et al. 2016). No upregulation of E-cadherin or claudin-1 was observed. Additionally, N-cadherin, a mesenchymal-associated cadherin, was not detected in the MDA-MB-231 (consistent with previous reports (Hazan et al. 1997; Nieman et al. 1999; Wang et al. 2002; Shankar and Nabi 2015) and could not be detected in the MDA-MB-231LG. However, MDA-MB-231 express cadherin-11 (Nieman et al. 1999; Wang et al. 2002; Li et al. 2011; Satriyo et al. 2019). Cadherin-11, like other cadherins, promotes cell–cell contact through homomeric extracellular interactions that help to link cytoskeletal proteins on the cytoplasmic side. Cadherin-11 is upregulated in invasive breast cancer (Assefnia et al. 2014; Pohlodek et al. 2016). Moreover, inhibition of cadherin-11 in the MDA-MB-231 decreased migration, growth in soft agar, stem cell marker expression, and in vivo tumor growth (Assefnia et al. 2014; Satriyo et al. 2019). The observation of higher cadherin-11 levels in the MDA-MB-231LG may contribute to the increase in cell–cell contact in these cells as it exhibited a membrane localized pattern, particularly at sites of cell–cell interaction. Interestingly, we observed a corresponding increase of cadherin-11 at sites of β-catenin near the plasma membrane. β-catenin exhibits multiple subcellular localizations within the nucleus, cytosol and plasma membrane corresponding to different functions and activity. β-catenin at the plasma membrane is involved in linking adherens junctions to cytoskeletal proteins such as actin and can contribute to cytoskeletal reorganization dynamics. The markers examined here represent only a small fraction of the many EMT, membrane and cytoskeletal proteins altered in cancer and further characterization is required to confirm a relationship. Nonetheless, these results suggest a potential relationship to the morphologic and membrane changes seen in the MDA-MB-231LG.
Since membrane contact is a fundamental aspect of GJIC, we explored if the plasma membrane interactions observed in the MDA-MB-231LG correlated with the formation of gap junctions. C×43 is highly expressed in breast tissue and one of the most well studied connexins altered during cancer progression. Similar to previous reports, we observed that parental MDA-MB-231 expressed low levels of C×43 with the absence of plasma membrane localization and GJIC in these cells (Qin et al. 2001; 2003, Jiang et al. 2017). Remarkably, C×43 protein was elevated in MDA-MB-231LG. We observed predominantly lower molecular weight forms of C×43 in each cell line similar to previous reports in MDA-MB-231 (Qin et al. 2002; Talhouk et al. 2013; Ming et al. 2015). However, the increase in C×43 indicated a potential adaptive response related to glucose levels and C×43 expression. Conversely, a recent report demonstrated an inverse relationship between high-glucose levels and C×43 expression in osteocyte-like cells (Yang et al. 2020). Augmented connexin protein levels alone are not capable of increasing GJIC when trafficking and membrane transport of connexin proteins remains dysregulated (Qin et al. 2001, 2003). Thus, we evaluated C×43 subcellular localization in MDA-MB-231LG cells and found an increase in the presence of this connexin at the membrane, indicative of connexon formation and membrane incorporation. To demonstrate function, we documented the ability of MDA-MB-231LG to transfer calcein to neighboring cells and noted an increase in GJIC. An important observation was that not all MDA-MB-231LG were coupled via gap junctions, and only a portion of the cells exhibited spread. However, the results described in this report regarding C×43 and GJIC are noteworthy because they developed as a consequence of the metabolic response to growth in glucose-limiting conditions without the influence of exogenous connexin expression or the use of pathway inhibitors or activators. Since this is a metabolic circumstance frequently overcome by cancer cells during tumor growth, it provides insight to a potential reprogramming response involving connexins and GJIC that may affect their ability to survive and adapt. Because the connexin family consists of 21 genes, some of which have been shown to be upregulated in different types of cancers and in response to different stimuli, we cannot exclude the influence of other connexins in the MDA-MB-231LG.
Because cancer cell invasion is a key initial feature of the metastatic process, and because GJIC has been shown to affect this process, we examined if these collective changes affected this aggressive quality. We used Matrigel to evaluate multiple three-dimensional in vitro growth models to characterize cellular invasion. Despite greater membrane contact, increased connexin expression and higher GJIC, all features more similar to normal epithelial cells, the MDA-MB-231LG demonstrated significantly higher invasive qualities in both the presence and absence of glucose, indicating intrinsic qualities in these cells. Previous studies which directly modulated expression of C×43 in the MDA-MB-231 cell line have shown reduction in proliferation, invasive characteristics in three-dimensional culture and an increased state of differentiation in response to C×43 expression while an inverse relationship was observed following reduction of C×43 (Qin et al. 2002; Shao et al. 2005; McLachlan et al. 2006; Talhouk et al. 2013). Some of these effects were attributed to gap junction independent functions of C×43. Other studies using this cell line have demonstrated both suppression and facilitation of aggressive and metastatic qualities in response to C×43 expression (Li et al. 2008; Fu et al. 2015; Lin et al. 2016; Kazan et al. 2019). Because this study examined the effects on C×43 expression as a result of changes to glucose metabolism, our results are therefore set amongst the background of this metabolic adaptation. Collectively, these studies emphasize the complexities related to the role of C×43 in cancer cells that are dependent upon experimental approach and context, highlighting the intricacies related to the study of GJIC and cancer.
To examine if the increase in invasiveness and GJIC in the MDA-MB-231LG were connected, we evaluated the invasive qualities of these cells during the inhibition of GJIC. We utilized 18α-glycerrehetinic acid (18αGA), a nonselective gap junction inhibitor which uncouples GJIC (Davidson et al. 1986; Salameh and Dhein 2005).The reduced invasive capacity of these cells in the presence of 18αGA indicated a potential link between these two attributes. The fact that not all MDA-MB-231LG exhibited GJIC must be considered when examining the change in invasiveness during 18αGA treatment. The effects on invasion under these conditions may have been more prominent if the population was more uniformly coupled by GJIC. Thus, careful delineation of these potential relationships will be of importance to our understanding of connexin function in response to metabolic regulation. The results of this study shed light on phenotypic changes that occur in response to nutrient withdrawal and further support a role for cellular metabolism on the regulation of connexins and gap junctional activity in this context.
Abbreviations
- C×43:
-
Connexin 43
- GJIC:
-
Gap junctional intercellular communication
References
Aasen T, Mesnil M, Naus CC et al (2016) Gap junctions and cancer: communicating for 50 years. Nat Rev Cancer 16(12):775–788
Amaro A, Angelini G, Mirisola V et al (2016) A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivo. Oncotarget 7(42):68803–68820
Assefnia S, Dakshanamurthy S, Guidry Auvil JM et al (2014) Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies. Oncotarget 5(6):1458–1474
Bates DC, Sin WC, Aftab Q et al (2007) Connexin43 enhances glioma invasion by a mechanism involving the carboxy terminus. Glia 55(15):1554–1564
Cailleau R, Young R, Olive M et al (1974) Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53(3):661–674
Chao YL, Shepard CR, Wells A (2010) Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer 9:179
Chen Q, Boire A, Jin X et al (2016) Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature 533(7604):493–498
Chiang SK, Chang WC, Chen SE et al (2019) DOCK1 regulates growth and motility through the RRP1B-claudin-1 pathway in claudin-low breast cancer cells. Cancers (Basel) 11(11):1762
Contreras JE, Sanchez HA, Eugenin EA et al (2002) Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc Natl Acad Sci 99(1):495–500
Czyz J, Irmer U, Schulz G et al (2000) Gap-junctional coupling measured by flow cytometry. Exp Cell Res 255(1):40–46
Davidson JS, Baumgarten IM, Harley EH (1986) Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. Biochem Biophys Res Commun 134(1):29–36
DeBerardinis RJ, Chandel NS (2016) Fundamentals of cancer metabolism. Sci Adv 2(5):e1600200
Dias K, Dvorkin-Gheva A, Hallett RM et al (2017) Claudin-low breast cancer; clinical & pathological characteristics. PLoS ONE 12(1):e0168669
Dovmark TH, Saccomano M, Hulikova A et al (2017) Connexin-43 channels are a pathway for discharging lactate from glycolytic pancreatic ductal adenocarcinoma cells. Oncogene 36(32):4538–4550
Dovmark TH, Hulikova A, Niederer SA et al (2018) Normoxic cells remotely regulate the acid-base balance of cells at the hypoxic core of connexin-coupled tumor growths. FASEB J 32(1):83–96
el-Sabban ME, Pauli BU (1994) Adhesion-mediated gap junctional communication between lung-metastatatic cancer cells and endothelium. Invasion Metastasis 14(1–6):164–176
Fu Y, Shao ZM, He QZ et al (2015) Hsa-miR-206 represses the proliferation and invasion of breast cancer cells by targeting C×43. Eur Rev Med Pharmacol Sci 19(11):2091–2104
Garcia-Jimenez C, Goding CR (2019) Starvation and pseudo-starvation as drivers of cancer metastasis through translation reprogramming. Cell Metab 29(2):254–267
Ghosh S, Kumar A, Tripathi RP et al (2014) Connexin-43 regulates p38-mediated cell migration and invasion induced selectively in tumour cells by low doses of gamma-radiation in an ERK-1/2-independent manner. Carcinogenesis 35(2):383–395
Gillies RJ, Schornack PA, Secomb TW et al (1999) Causes and effects of heterogeneous perfusion in tumors. Neoplasia 1(3):197–207
Goldberg GS, Bechberger JF, Naus CC (1995) A pre-loading method of evaluating gap junctional communication by fluorescent dye transfer. Biotechniques 18(3):490–497
Hazan RB, Kang L, Whooley BP et al (1997) N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun 4(6):399–411
Hollestelle A, Nagel JH, Smid M et al (2010) Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Res Treat 121(1):53–64
Hong X, Sin WC, Harris AL et al (2015) Gap junctions modulate glioma invasion by direct transfer of microRNA. Oncotarget 6(17):15566–15577
Jiang G, Dong S, Yu M et al (2017) Influence of gap junction intercellular communication composed of connexin 43 on the antineoplastic effect of adriamycin in breast cancer cells. Oncol Lett 13(2):857–866
Kazan JM, El-Saghir J, Saliba J et al (2019) C×43 expression correlates with breast cancer metastasis in MDA-MB-231 cells in vitro, in a mouse xenograft model and in human breast cancer tissues. Cancers (Basel) 11(4):460
King TJ, Lampe PD (2004) The gap junction protein connexin32 is a mouse lung tumor suppressor. Cancer Res 64(20):7191–7196
Lamiche C, Clarhaut J, Strale PO et al (2012) The gap junction protein C×43 is involved in the bone-targeted metastatic behaviour of human prostate cancer cells. Clin Exp Metastasis 29(2):111–122
Li Z, Zhou Z, Donahue HJ (2008) Alterations in C×43 and OB-cadherin affect breast cancer cell metastatic potential. Clin Exp Metastasis 25(3):265–272
Li Y, Guo Z, Chen H et al (2011) HOXC8-dependent cadherin 11 expression facilitates breast cancer cell migration through trio and rac. Genes Cancer 2(9):880–888
Lin ZJ, Ming J, Yang L et al (2016) Mechanism of regulatory effect of MicroRNA-206 on Connexin 43 in distant metastasis of breast cancer. Chin Med J (Engl) 129(4):424–434
Liu CY, Lin HH, Tang MJ et al (2015) Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation. Oncotarget 6(18):15966–15983
Liu F, Gu LN, Shan BE et al (2016) Biomarkers for EMT and MET in breast cancer: an update. Oncol Lett 12(6):4869–4876
Louie E, Nik S, Chen JS et al (2010) Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation. Breast Cancer Res 12(6):R94
Majer A, Blanchard AA, Medina S et al (2016) Claudin 1 expression levels affect miRNA dynamics in human basal-like breast cancer cells. DNA Cell Biol 35(7):328–339
Mattern J, Roghi CS, Hurtz M et al (2019) ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells. Sci Rep 9(1):12540
McLachlan E, Shao Q, Wang HL et al (2006) Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res 66(20):9886–9894
Mehta PP, Hotz-Wagenblatt A, Rose B et al (1991) Incorporation of the gene for a cell-cell channel protein into transformed cells leads to normalization of growth. J Membr Biol 124(3):207–225
Ming J, Zhou Y, Du J et al (2015) miR-381 suppresses C/EBPalpha-dependent C×43 expression in breast cancer cells. Biosci Rep 35(6):e00266
Morata-Tarifa C, Jimenez G, Garcia MA et al (2016) Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells. Sci Rep 6:18772
Nielsen MS, Axelsen LN, Sorgen PL et al (2012) Gap junctions. Compr Physiol 2(3):1981–2035
Nieman MT, Prudoff RS, Johnson KR et al (1999) N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147(3):631–644
Ogawa K, Pitchakarn P, Suzuki S et al (2012) Silencing of connexin 43 suppresses invasion, migration and lung metastasis of rat hepatocellular carcinoma cells. Cancer Sci 103(5):860–867
Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23(1):27–47
Pishvaian MJ, Feltes CM, Thompson P et al (1999) Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 59(4):947–952
Pohlodek K, Tan YY, Singer CF et al (2016) Cadherin-11 expression is upregulated in invasive human breast cancer. Oncol Lett 12(6):4393–4398
Qin H, Shao Q, Belliveau DJ et al (2001) Aggregated DsRed-tagged C×43 and over-expressed C×43 are targeted to lysosomes in human breast cancer cells. Cell Commun Adhes 8(4–6):433–439
Qin H, Shao Q, Curtis H et al (2002) Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J Biol Chem 277(32):29132–29138
Qin H, Shao Q, Igdoura SA et al (2003) Lysosomal and proteasomal degradation play distinct roles in the life cycle of C×43 in gap junctional intercellular communication-deficient and -competent breast tumor cells. J Biol Chem 278(32):30005–30014
Salameh A, Dhein S (2005) Pharmacology of gap junctions. New pharmacological targets for treatment of arrhythmia, seizure and cancer? Biochim Biophys Acta 1719(1–2):36–58
Satriyo PB, Bamodu OA, Chen JH et al (2019) Cadherin 11 inhibition downregulates beta-catenin, deactivates the canonical WNT signalling pathway and suppresses the cancer stem cell-like phenotype of triple negative breast cancer. J Clin Med 8(2):148
Shankar J, Nabi IR (2015) Actin cytoskeleton regulation of epithelial mesenchymal transition in metastatic cancer cells. PLoS ONE 10(3):e0119954
Shao Q, Wang H, McLachlan E et al (2005) Down-regulation of C×43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype. Cancer Res 65(7):2705–2711
Simoes RV, Serganova IS, Kruchevsky N et al (2015) Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment. Neoplasia 17(8):671–684
Talhouk RS, Fares MB, Rahme GJ et al (2013) Context dependent reversion of tumor phenotype by connexin-43 expression in MDA-MB231 cells and MCF-7 cells: role of beta-catenin/connexin43 association. Exp Cell Res 319(20):3065–3080
Tang B, Peng ZH, Yu PW et al (2013) Aberrant expression of C×43 is associated with the peritoneal metastasis of gastric cancer and C×43-mediated gap junction enhances gastric cancer cell diapedesis from peritoneal mesothelium. PLoS ONE 8(9):e74527
Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49(23):6449–6465
Wang F, Hansen RK, Radisky D et al (2002) Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer Inst 94(19):1494–1503
Wang WK, Chen MC, Leong HF et al (2014) Connexin 43 suppresses tumor angiogenesis by down-regulation of vascular endothelial growth factor via hypoxic-induced factor-1alpha. Int J Mol Sci 16(1):439–451
Wang X, Liu Y, Zhou K et al (2015) Isolation and characterization of CD105 +/CD90 + subpopulation in breast cancer MDA-MB-231 cell line. Int J Clin Exp Pathol 8(5):5105–5112
Yang L, Zhou G, Li M et al (2020) High glucose downregulates Connexin 43 expression and its gap junction and hemichannel function in osteocyte-like MLO-Y4 cells through activation of the p38MAPK/ERK signal pathway. Diabetes Metab Syndr Obes 13:545–557
Zibara K, Awada Z, Dib L et al (2015) Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo. Sci Rep 5:12598
Acknowledgements
We are grateful to the Chicago College of Pharmacy for a Student Research Fellowship to AMM and the Chicago College of Osteopathic Medicine for Kenneth A. Suarez Research Fellowships to PPJ, AEU and CSK. We are indebted to equipment and valuable expertise provided within the Midwestern University Core Facility, Downers Grove, IL.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
12079_2020_601_MOESM1_ESM.tif
Validation of cellular viability assay by flow cytometry in MDA-MB-231. a, Caspase 3/7 positive control conditions were prepared by treating cells with 1µM staurosporine for 18 h. b, SYTOX positive controls were prepared by heat killing cells at 65 oC for 5 minutes. (TIFF 1277 kb)
12079_2020_601_MOESM2_ESM.tif
Demonstration of gap junction assay using calcein and CM-DiI. Hs578T exhibit high levels of GJIC. a, Donor cells were loaded with CM-DiI and calcein and co-cultured with acceptor cells for 6 h. Spread of calcein from double-labeled donor cells indicates activity of GJIC. Calcein: green; CM-DiI: red. Scale bar: 50 µm; n = 3. b, Quantification of gap junction assay by flow cytometry using Cell Tracker Red to mark donor cells. Double-labeled donor cell populations appear in upper-right quadrant when calcein is plotted on the x-axis and Cell Tracker Red plotted on the y-axis. Non-labeled cells appear in lower-left quadrant indicating absence of both dyes. Following 6 h co-culture of these populations at a ratio of 1:20 donor cell/acceptor cell for 6 h, calcein-only positive acceptor populations appear in the lower-right quadrant. Coupling efficiency is calculated as the number of acceptor cells divided by the number of donor cells in the experiment ± SD. (TIFF 9174 kb)
12079_2020_601_MOESM3_ESM.tif
Lysates of HEK293T cells with empty vector control and Cx43 overexpression were analyzed by western blot analysis. Arrows indicate multiple molecular weight bands for Cx43. GAPDH was used as a loading control. (TIFF 1486 kb)
12079_2020_601_MOESM4_ESM.tif
Additional fields of Cx43 immunofluorescence in MDA-MB-231 (a) and MDA-MB-231LG (b) as described in Figure 4. DAPI: blue; Cx43: green; actin: red. Scale bar represents 20 µm. (TIFF 30503 kb)
12079_2020_601_MOESM5_ESM.tif
STR analysis of Hs578T, MCF7 and T47D. Asterisk indicate 9 markers defined by ATCC criteria for 100% match. (TIFF 3004 kb)
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jones, J.C., Miceli, A.M., Chaudhry, M.M. et al. Glucose-limiting conditions induce an invasive population of MDA-MB-231 breast cancer cells with increased connexin 43 expression and membrane localization. J. Cell Commun. Signal. 15, 223–236 (2021). https://doi.org/10.1007/s12079-020-00601-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12079-020-00601-3